Lieke Wever

886 total citations
14 papers, 647 citations indexed

About

Lieke Wever is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and General Health Professions. According to data from OpenAlex, Lieke Wever has authored 14 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Rheumatology and 3 papers in General Health Professions. Recurrent topics in Lieke Wever's work include Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Urologic and reproductive health conditions (5 papers). Lieke Wever is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (7 papers), Prostate Cancer Treatment and Research (7 papers) and Urologic and reproductive health conditions (5 papers). Lieke Wever collaborates with scholars based in Netherlands and Italy. Lieke Wever's co-authors include Symone Detmar, Jan H. Schornagel, Neil K. Aaronson, Martin J. Muller, Mirjam A. G. Sprangers, K.C.A. Sneeuw, Martin Müller, Roderick C.N. van den Bergh, Harm H.E. van Melick and Timo Soeterik and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and British Journal of Urology.

In The Last Decade

Lieke Wever

14 papers receiving 616 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lieke Wever Netherlands 8 288 249 209 148 103 14 647
Carole Bouleuc France 14 344 1.2× 290 1.2× 282 1.3× 109 0.7× 129 1.3× 68 903
Carole Seigel United States 7 243 0.8× 363 1.5× 191 0.9× 174 1.2× 107 1.0× 8 723
Daniel E. Lage United States 14 307 1.1× 408 1.6× 154 0.7× 152 1.0× 79 0.8× 36 761
Ellen Mason United States 13 311 1.1× 204 0.8× 176 0.8× 100 0.7× 64 0.6× 29 831
Schroder Sattar Canada 20 292 1.0× 216 0.9× 176 0.8× 69 0.5× 153 1.5× 52 899
Kate Clay United States 6 327 1.1× 258 1.0× 494 2.4× 156 1.1× 97 0.9× 10 925
Beate Hornemann Germany 15 385 1.3× 236 0.9× 153 0.7× 166 1.1× 71 0.7× 58 607
Samantha Mayo Canada 13 349 1.2× 208 0.8× 100 0.5× 145 1.0× 147 1.4× 46 652
Annemarie Coolbrandt Belgium 16 368 1.3× 259 1.0× 124 0.6× 196 1.3× 132 1.3× 37 682
Esmé Finlay United States 12 331 1.1× 530 2.1× 229 1.1× 271 1.8× 80 0.8× 23 1.0k

Countries citing papers authored by Lieke Wever

Since Specialization
Citations

This map shows the geographic impact of Lieke Wever's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lieke Wever with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lieke Wever more than expected).

Fields of papers citing papers by Lieke Wever

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lieke Wever. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lieke Wever. The network helps show where Lieke Wever may publish in the future.

Co-authorship network of co-authors of Lieke Wever

This figure shows the co-authorship network connecting the top 25 collaborators of Lieke Wever. A scholar is included among the top collaborators of Lieke Wever based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lieke Wever. Lieke Wever is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Kelder, Johannes C., Timo Soeterik, Lieke Wever, et al.. (2024). The additional value of 68Ga‐PSMA PET/CT SUVmax in predicting ISUP GG ≥ 2 and ISUP GG ≥ 3 prostate cancer in biopsy. The Prostate. 84(11). 1025–1032. 4 indexed citations
2.
Wever, Lieke, Timo Soeterik, Jules Lavalaye, et al.. (2023). Is cribriform pattern in prostate biopsy a risk factor for metastatic disease on 68Ga-PSMA-11 PET/CT?. World Journal of Urology. 41(8). 2165–2171. 1 indexed citations
3.
Lavalaye, Jules, Timo Soeterik, Lieke Wever, et al.. (2023). Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Active Surveillance for Prostate Cancer Trial (PASPoRT). European Urology Oncology. 7(2). 204–210. 14 indexed citations
4.
Kelder, Johannes C., Timo Soeterik, Lieke Wever, et al.. (2023). The additional value of 68Ga-PSMA PET/CT SUVmax in predicting ISUP GG=2 and ISUP GG=3 prostate cancer in biopsy. European Urology Open Science. 57. S23–S24. 1 indexed citations
5.
Wever, Lieke, et al.. (2022). Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?. European Urology Open Science. 44. 30–32. 3 indexed citations
6.
Soeterik, Timo, et al.. (2022). A side-specific nomogram for extraprostatic extension may reduce the positive surgical margin rate in radical prostatectomy. World Journal of Urology. 40(12). 2919–2924. 7 indexed citations
7.
Wever, Lieke, Hielke M. de Vries, Paolo Dell’Oglio, et al.. (2022). Incidence and risk factor analysis of complications after sentinel node biopsy for penile cancer. British Journal of Urology. 130(4). 486–495. 13 indexed citations
8.
Bergh, Roderick C.N. van den, Lieke Wever, & Harm H.E. van Melick. (2021). TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee. European Urology Open Science. 32. 43–44. 1 indexed citations
10.
Wever, Lieke, Hielke M. de Vries, Henk G. van der Poel, et al.. (2020). Minimally invasive evaluation of the clinically negative inguinal node in penile cancer: Dynamic sentinel node biopsy. Urologic Oncology Seminars and Original Investigations. 40(6). 209–214. 7 indexed citations
11.
Detmar, Symone, Martin Müller, Jan H. Schornagel, Lieke Wever, & Neil K. Aaronson. (2002). Role of Health-Related Quality of Life in Palliative Chemotherapy Treatment Decisions. Journal of Clinical Oncology. 20(4). 1056–1062. 33 indexed citations
12.
Detmar, Symone, Neil K. Aaronson, Lieke Wever, Martin J. Muller, & Jan H. Schornagel. (2000). How Are You Feeling? Who Wants To Know? Patients’ and Oncologists’ Preferences for Discussing Health-Related Quality-of-Life Issues. Journal of Clinical Oncology. 18(18). 3295–3301. 270 indexed citations
13.
Sneeuw, K.C.A., Neil K. Aaronson, Mirjam A. G. Sprangers, et al.. (1999). Evaluating the quality of life of cancer patients: assessments by patients, significant others, physicians and nurses. British Journal of Cancer. 81(1). 87–94. 163 indexed citations
14.
Aaronson, Neil K., et al.. (1997). Value of caregiver ratings in evaluating the quality of life of patients with cancer.. Journal of Clinical Oncology. 15(3). 1206–1217. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026